How it should be taken
It comes as a solution for injection to be administered by a healthcare provider into the vein. Warm diluent (Sterile Water for Injection, USP) and concentrate (Alphanate (antihemophilic factor) ) to at least room temperature (but not above 37 °C).
Dosage & When it is to be taken
IV- The recommended dose is 5 –10 U/kg, repeated 6 to 12 hourly.
When it is not to be taken (Contraindications)
Why it is prescribed (Indications)
This medication is an essential blood-clotting factor, prescribed for controlling and preventing bleeding episodes in people with low levels of factor VIII (hemophilia A) and AHG deficiency. This product contains a man-made form of factor VIII, also called antihemophilic factor. This temporarily replaces the missing factor VIII, a protein (clotting factor) that is normally in the blood, so that the blood can clot and the bleeding can stop.
Category C :
Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Warnings and Precautions
Caution needed in pregnant and breastfeeding women.
This medication should not be used to treat von Willebrand disease.
It may cause dizziness, do not drive a car or operate machinery while taking this medication.
Store it in refrigerator (2 to 8°C), do not freeze it. May be stored at room temperature not to exceed 30 °C for up to 2 months.